A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Tachycardia, Ventricular
- Sponsor
- Duke University
- Enrollment
- 151
- Locations
- 1
- Primary Endpoint
- Re-hospitalization and ED visits for cardiac causes, unscheduled clinic visits for device-related issues, medications, patient logs, patients' level of satisfaction with their device care at baseline, 6 months, and 12 months.
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
The purpose of this study is to determine if remote monitoring of implantable cardioverter defibrillators (ICD), compared with quarterly device interrogations in clinic, will improve patients' outcomes and satisfaction and will reduce health care costs.
Detailed Description
Sudden cardiac death (SCD), usually due to a ventricular tachyarrhythmia, is the most common cause of death in the United States. The implantable cardioverter defibrillator (ICD) has been shown to improve the survival of patients with a history of a heart attack and a weak heart (functioning at 30% or less) and those with symptomatic congestive heart failure symptoms (hearts functioning at 35% or less). Thus, the number of patients who will require ICD therapy is expected to rise exponentially over the next several years. To facilitate the follow-up of patients with ICDs, device companies have launched systems for remote monitoring of these devices. One such system is the Medtronic Carelink Monitor. Although this system has been proven in a multicenter, prospective study to be easy to use, it is not known whether this monitor results in improved patients' outcomes and satisfaction and in reduced healthcare costs. Comparison: Patient outcomes, costs, and satisfaction will be evaluated, comparing patients assigned to follow-up using the Medtronic Carelink Monitor versus quarterly visits to an outpatient clinic.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years of age or older
- •Must have an ICD with or without CRT for an approved indication
- •Must be planning to have their devices followed-up at Duke
- •Must have a telephone (land line)
- •Willing and able to provide informed consent.
Exclusion Criteria
- •18 years of age or younger
- •No telephone with land line
- •Unable to provide informed consent.
Outcomes
Primary Outcomes
Re-hospitalization and ED visits for cardiac causes, unscheduled clinic visits for device-related issues, medications, patient logs, patients' level of satisfaction with their device care at baseline, 6 months, and 12 months.
Time Frame: 12 months
Secondary Outcomes
- Health-related quality of life at baseline, 6 months, and 12 months. Health utilization costs incurred during the study period.(12 months)